FR2224140A1 - Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions - Google Patents

Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions

Info

Publication number
FR2224140A1
FR2224140A1 FR7312255A FR7312255A FR2224140A1 FR 2224140 A1 FR2224140 A1 FR 2224140A1 FR 7312255 A FR7312255 A FR 7312255A FR 7312255 A FR7312255 A FR 7312255A FR 2224140 A1 FR2224140 A1 FR 2224140A1
Authority
FR
France
Prior art keywords
veterinary
compns
internal
polyvinyl pyrrolidone
external treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7312255A
Other languages
French (fr)
Other versions
FR2224140B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHALAUST RENE FR
Original Assignee
CHALAUST RENE FR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHALAUST RENE FR filed Critical CHALAUST RENE FR
Priority to FR7312255A priority Critical patent/FR2224140A1/en
Publication of FR2224140A1 publication Critical patent/FR2224140A1/en
Application granted granted Critical
Publication of FR2224140B1 publication Critical patent/FR2224140B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone

Abstract

Therapeutic compsns. comprising as active component polyvinylpolyprrolidone (I) optionally together with coccidiostats, sulphonamides, antiseptics, antibiotics, adsorbents and vitamines are useful in veterinary treatment of gastrointestinal, inflammatory and gynaecological conditions, internally or externally; (I) are insoluble in acids and alkalis, non-allergic and non-toxic, and adsorb toxins in their three-dimensional network allowing tissues to regenerate.
FR7312255A 1973-04-05 1973-04-05 Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions Granted FR2224140A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7312255A FR2224140A1 (en) 1973-04-05 1973-04-05 Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7312255A FR2224140A1 (en) 1973-04-05 1973-04-05 Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions

Publications (2)

Publication Number Publication Date
FR2224140A1 true FR2224140A1 (en) 1974-10-31
FR2224140B1 FR2224140B1 (en) 1976-04-09

Family

ID=9117453

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7312255A Granted FR2224140A1 (en) 1973-04-05 1973-04-05 Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions

Country Status (1)

Country Link
FR (1) FR2224140A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2414917A1 (en) * 1978-01-24 1979-08-17 Schiapparelli Spa Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
EP0035142A2 (en) * 1980-02-22 1981-09-09 BASF Aktiengesellschaft Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions
US4289749A (en) * 1979-08-14 1981-09-15 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing phenylpropanolamine
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
EP2186521A1 (en) * 2008-11-14 2010-05-19 Mergemeier Steffen Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2414917A1 (en) * 1978-01-24 1979-08-17 Schiapparelli Spa Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4292303A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing clonidine
US4289749A (en) * 1979-08-14 1981-09-15 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing phenylpropanolamine
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4292302A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing terbutaline
US4292301A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing ephedrine
US4294820A (en) * 1979-08-14 1981-10-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing phenylephrine
EP0035142A2 (en) * 1980-02-22 1981-09-09 BASF Aktiengesellschaft Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions
EP0035142A3 (en) * 1980-02-22 1982-06-23 BASF Aktiengesellschaft Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions
EP2186521A1 (en) * 2008-11-14 2010-05-19 Mergemeier Steffen Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound
WO2010054858A2 (en) * 2008-11-14 2010-05-20 Steffen Mergemeier Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
WO2010054858A3 (en) * 2008-11-14 2010-08-19 Steffen Mergemeier Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens

Also Published As

Publication number Publication date
FR2224140B1 (en) 1976-04-09

Similar Documents

Publication Publication Date Title
CA942894A (en) Patient treatment table
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
ES2151607T3 (en) GROWTH AND DIFFERENTIATION FACTOR 12.
FR2224140A1 (en) Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions
IE40860B1 (en) Substituted benzamides
SE9201930D0 (en) GASTRIC ANTIBACTERIAL TREATMENT
IL39212A0 (en) N-(dimethylaminomethylidene)-thiol and-thiono-phosphoric acid ester imides,their preparation and their use as insecticides or acaricides
AU462701B2 (en) Polymer biologically active protein complexes
FR2282903A1 (en) TRIACYL ESTERS IN 9.3 '', 4 '' POSITIONS OF THE SF-837 M1 ANTIBIOTIC AND ASSOCIATED PREPARATION PROCESS
CA931666A (en) Patient treatment table
SE7908636L (en) USE OF SALINOMYCIN AS AN EFFECTIVE SUBSTANCE TO IMPROVE NUTRITION AND ADMINISTRATION OF RUMINATORS AND ANIMAL SPECIES WITH SIMILAR DIGESTION PHYSIOLOGY
AU454611B2 (en) Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents
AU471736B2 (en) N-(aminomethylidene0-thiol-phosphoric acid ester imides, process for their manufacture and their use as insecticides and acaricides
IT956328B (en) POROUS BODY RIGIDED AT THE EDGES PROCEDURE AND DEVICE FOR THE PRODUCTION OF THE SAME
AU4851072A (en) Air supply manifold fora hydrotherapy treatment system
IE811449L (en) Pyrrolidine derivatives.
CA1019122A (en) Modacrylic filaments wet-spun from solution in three-stage coagulation
EP0058015A3 (en) Treatment of infections
TR17151A (en) DISUBSTITUEE N- (AMINOMETYLIDEN) -TIOL (TIONO) PHOSPHORIC ACID ESTER IMIDES, PROCEDURES SPECIFIC TO ITS PRODUCTS AND INSECTICIDES AND THEIR USE AS MISCIDES
SU628904A1 (en) Anesthesia method
CA945163A (en) Acryloyl-2 benzimidazoles, leur procede de preparation et leur application en therapeutique
CA989836A (en) Substituted axazino (5,6,e) indole, its manufacturing process and therapeutic application
CA998679A (en) Substituted benzimidazoles, their preparation and use
MX9710126A (en) Substituted compounds with sulphonamide, process for its preparation, its use as a medicament or diagnostic agent as well as pharmaceutical preparations.
GB769331A (en) Improvements in or relating to the storage of articles

Legal Events

Date Code Title Description
ST Notification of lapse